News

Economic Outlook Raises Concerns of Inflation Under Trump

Economic Outlook Raises Concerns of Inflation Under Trump

Increased Economic Concerns with Trump's Return

Recent findings reveal that economists are increasingly worried about the potential return of former President Donald Trump and its effects on inflation and federal deficits.

Survey Findings on Inflation and Economic Policies

A survey conducted by a group of economists indicates a majority foresee higher inflation and federal deficits under Trump's economic policies compared to those proposed by Vice President Kamala Harris. The survey's results, gathered from October 4-8, show that a rising percentage of economists expect inflation rates to outpace those experienced under Harris's administration.

Key Statistics from the Survey

According to the results, 68% of economists believe that inflation will rise more rapidly under Trump, marking an increase from 56% reported in a similar study conducted in July. Only 12% feel that Harris's approach would contribute to higher inflation, with most of the remaining economists seeing no significant differences between the two.

Impacts of Tariff Policies on Consumer Prices

Significant attention has been directed toward Trump's plans to impose tariffs on imports. These tariffs are set to range between 10% and 20%, with a staggering 60% or more specific to Chinese imports. Economists warn that these tariffs could lead to a notable rise in consumer costs. For instance, Dan Hamilton, an economist at California Lutheran University, commented that Trump’s staunch anti-free-trade position could exacerbate inflationary pressures.

Federal Deficit Projections Under Trump

The prediction for a rising federal deficit under Trump is also concerning. Approximately 65% of economists in the survey believe that his policies would exacerbate the deficit, a noticeable increase from 51% just a few months prior. The Committee for a Responsible Federal Budget estimates that Trump's fiscal strategies could add around $7.5 trillion to the federal deficit over the course of a decade, which is significantly higher than Harris's anticipated impact.

Trump's Vision for Lower Energy Costs

Trump's focus on reducing energy costs has resonated during discussions surrounding inflation. He has articulated strategies to alleviate economic pressures, such as lowering energy prices with the goal of reducing overall inflation rates and interest charges. This approach aligns with a broader attempt to address consumers' financial struggles amidst soaring inflation rates.

Concerns Over Tax Cuts and Mass Deportations

However, his proposals for extensive tax cuts, increased tariffs, and plans for mass deportation of undocumented immigrants have raised alarm among economists, suggesting these could lead to inflation spikes. At a recent address at the New York Economic Club, Trump downplayed the implications of childcare costs, asserting that revenue generated from tariffs would yield “trillions of dollars” for the U.S. economy.

Support from Economic Advisors

Scott Bessent, a prominent economic advisor to Trump, stood by the former president’s policies, stating that an administration led by Trump would foster a strong dollar. This assertion comes at a time when earlier discussions indicated a weaker dollar might promote export growth.

Looking Toward the Future

As the political landscape continues to evolve, the economic implications of a potential Trump return demonstrate nuanced considerations for American consumers and investors alike. Questions linger about how these policies will actually play out in practical terms and what their broader implications might be for the U.S. economy.

Frequently Asked Questions

What are the major economic concerns with Trump's policies?

Many economists fear that Trump’s return could lead to increased inflation rates and federal deficits, particularly due to his proposed tariffs and other economic strategies.

How do Trump's tariffs affect consumer prices?

Trump's tariffs, expected to range from 10% to over 60%, may raise consumer costs significantly, contributing to higher inflation.

What percentage of economists predict a rise in inflation under Trump?

Currently, 68% of surveyed economists predict that inflation will rise more rapidly under Trump's economic policies compared to Harris's.

What's the projected increase in the federal deficit under Trump?

Estimates suggest that Trump’s economic plans could increase the federal deficit by approximately $7.5 trillion over the next decade.

How does Trump plan to reduce energy costs?

Trump has emphasized lowering energy prices as a crucial step in combating inflation and easing the economic burden on consumers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 4

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 8

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Boost for Inseego as George Mulhern Joins Board

Updated Category News Views 140

Inseego Welcomes George Mulhern to Its Board of Directors Inseego Corp. (Nasdaq: INSG) is thrilled to announce the appointment of George Mulhern, a distinguished leader in the wireless technology sector, to its Board of Directors. With a profound background in developing and steering wireless tech companies, Mr. Mulhern has most recently held the position of Senior Vice...

Continue Reading
Economic Outlook Raises Concerns of Inflation Under Trump

Updated Category News Views 128

Increased Economic Concerns with Trump's Return Recent findings reveal that economists are increasingly worried about the potential return of former President Donald Trump and its effects on inflation and federal deficits. Survey Findings on Inflation and Economic Policies A survey conducted by a group of economists indicates a majority foresee higher inflation and...

Continue Reading
Join the Class Action Against Rocket Pharmaceuticals Today

Updated Category News Views 134

Join the Class Action Against Rocket Pharmaceuticals Investors are being called to participate in a class action lawsuit concerning Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). This lawsuit is aimed at recovering losses incurred by shareholders due to alleged securities fraud that impacted the company's financial standing during a specified timeframe. Understanding the...

Continue Reading
Nipocalimab Receives Priority Review from U.S. FDA for gMG

Updated Category News Views 297

Nipocalimab Secures U.S. FDA Priority Review Status Johnson & Johnson (NYSE: JNJ) has exciting news regarding its investigational drug, Nipocalimab. The U.S. Food and Drug Administration (FDA) has granted Priority Review designation for Nisocalimab as a treatment for generalized myasthenia gravis (gMG) in patients with specific autoantibodies. This important milestone...

Continue Reading
Navigating the Canadian Multifamily Landscape: Supply and Demand

Updated Category News Views 89

Understanding Canada's Multifamily Market Trends In recent times, the Canadian multifamily housing market has exhibited some intriguing trends, particularly concerning rent growth and vacancy rates. As highlighted in the latest report from Yardi Canada, the market showcases a scenario where rent growth is slowing, while vacancies remain low. This situation reflects the...

Continue Reading